Skip to main content
OpenTrials
Enrolling by invitation

NCT Number: NCT07772661

Comaparative Effects of Bowen Technqiue With and Withour Extracorporeal Shock Wave in Patientys With Deep Gliteal Pain Syndrome.

A single-blinded, randomized controlled trial consisting of 46 participants with Deep Gluteal syndrome, calculated by the G power tool with an attrition rate of 5 % will be conducted. Participants will be recruited using non-probability convenience sampling based on pre-defined inclusion and exclusion criteria. Participants will be randomly assigned into two groups with 23 participants each group. Group A will receive Bowen Technique with extracorporeal shockwave therapy. Group B will receive Bowen Technique without extracorporeal shockwave therapy in conjunction with conventional therapy. Primary outcomes like pain, functional level and ROM will be measured at baseline and post-intervention using the Lower extremity functional scale (LEFS), Numeric Pain Rating scale (NPRS), and Goniometer. Data will be analyzed by IBM SPSS 26.0 with the Shapiro-Wilk test to confirm the normality.

Enrolling by invitation

Interested in participating?

Request Info

Key information

Age range

25 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Management and technology Sialkot Campus

Sialkot, Punjab Province, 51070, Pakistan

About this study

This randomized controlled trial investigates the effects of Bowen Technique with and without Extracorporeal Shockwave Therapy in patients with Deep Gluteal Syndrome. The study includes 46 participants, with 23 participants allocated to each group. Group A receives Bowen Technique combined with ESWT, while Group B receives Bowen Technique without ESWT, with both groups receiving standardized physiotherapy. The main outcomes assessed are pain intensity, lower-limb function, hip range of motion, and clinical provocation tests including the FAIR Test, Active Piriformis Test, and Seated Piriformis Stretch Test. NPRS, LEFS, universal goniometry, and the clinical special tests are used to evaluate changes from baseline to post-treatment. The study aims to determine whether adding ESWT to Bowen Technique provides greater clinical benefit than Bowen Technique alone in patients with Deep Gluteal Syndrom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals aged 25 to 45 years, including both genders 55
  • Positive FAIR, Active Piriformis Test, Seated Piriformis Stretch Test 56,6,57
  • NPRS pain score ≥ 3/10 55
  • For a minimum of four weeks, there has been unilateral discomfort in the buttock, with or without accompanying posterior thigh pain, exacerbated by sitting 58

Exclusion criteria

  • Previous surgery involving the ipsilateral hip, pelvis, lumbar spine, or sacroiliac joint 34
  • Women who were pregnant or nursing were excluded 59
  • Medical conditions such as tumors or fractures 60
  • Neuromuscular disorders that impair normal lumbopelvic morphology or progressive neurologic disease 60
  • Disc pathologies identified through radiological imaging 17
  • Pathologies of the hip joint and soft tissues 17
  • Recent trauma history 17
  • History of polyneuropathy, sciatic nerve injury, rheumatological disease, or malignancy 17
  • Corticosteroid therapy or opioid-derived analgesia for pain during the previous month 17

Treatment and study plan

Experimental : Group A = Bowen With ESWT

Other

Bowen Technique is a gentle manual fascial technique used to reduce muscle tension, pain, and soft-tissue restriction. ESWT is a non-invasive mechanical treatment that delivers shockwaves to promote analgesia, circulation, and tissue repair. In Deep Gluteal Syndrome, both can target the painful and restricted deep gluteal tissues, so my study compares Bowen alone with Bowen combined with ESWT to determine whether the addition of ESWT provides greater clinical benefit

Control Group: Group B= Bowen Techniques only

Other

The Bowen Technique is a gentle manual soft-tissue technique developed by Thomas Bowen. It uses slow, precise, cross-fiber rolling movements over muscles, tendons, ligaments, and fascia, with short rest periods between sets of movements. In your study, the therapist applies gentle pressure to the deep gluteal muscles, holds the tissue briefly, then moves across it in a controlled manner.

Primary outcomes

  1. UNIVERSAL GONIOMETRY

    Time frame: 6 Weeks

    A goniometer is a conventional clinical tool utilized to assess joint range of motion (ROM), offering objective and dependable measurements to assess mobility restrictions in musculoskeletal disorders72

    . Goniometric measurement of passive hip ROM has good test-retest reliability, with

    ICC ranging from 0.82 to 0.94 across different hip movements79

    • For goniometric evaluation of hip internal rotation, the minimal detectable change (MDC) is 8.6°, and for hip external rotation, it is 6.1° 18
    • According to anchor-based methodology, the minimal clinically significant difference (MCID) for hip range of motion is 5.81° 80
  2. NUMERICAL PAIN RATING SCALE (NPRS)

    Time frame: 6 Weeks

    The Numeric Pain Rating Scale (NPRS) is a self-reported metric utilized to evaluate pain severity in individuals with musculoskeletal conditions 70

    • It is a simple 11-point scale that ranges from 0 (no pain) to 10 (worst pain imaginable) that can be administered verbally or in writing 74
    • which shows multilevel likelihood ratios of 0.99 (scores 1-3), 2.67 (scores 4-6), and 5.60 (scores 7-10) for detecting pain-related functional interference, and an established sensitivity of 69 percent at ascore of 175 .Patients are asked to rate their current, best, and worst pain levels during the previous 24 hours, and the average of the three values is used to get the final pain intensity score 76 The NPRS minimal clinically significant difference (MCID) in this current study was set at two points 77 . The NPRS is widely used in research and clinical environments due to its ease of use, high reliability, validity, and responsiveness to clinically relevant changes in both acute and chronic

Secondary outcomes

  1. LEFS

    Time frame: 6 Weeks

    The Lower Extremity Functional Scale (LEFS) is a patient-reported outcome measure utilized to evaluate functional impairments in individuals with lower extremity musculoskeletal disorders 71

    . There are twenty items in the LEFS, and the scores range from 0 (extreme difficulty/unable to perform activity) to 4 (no difficulty). By adding up the scores for each item, the overall score can be found. Extreme limitations are indicated by a score of 0, while a maximum score of 80 denotes no functional limitations82

    • When compared to the SF-36, the LEFS's construct validity was confirmed, and its sensitivity to change was higher than the SF-36's.The subgroup of patients with more chronic conditions showed excellent test-retest reliability (r = 0.94; 95 percent lower limit CI = 0.89) 71
    • When tested against the Timed Up and Go (TUG) test as an external criterion, the LEFS showed exceptional diagnostic accuracy with a sensitivity of 92% and specificity of 96% at a cut-off score of 53

Sponsors and collaborators

Lead sponsor

University of Management and Technology Sialkot Pakistan

Other

Registry information

Official study title

Cpmparative Effects of Bowen Technqiue With and Without Extracorporeal Shockwave in Patients With Deep Glueteal Pain Syndrome; a Randomized Control Trail

Acronym: Bowen+ESWT

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Aug 19, 2026
Registry last updated
Aug 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.